Germ cell malignancies of the ovary.
Historically, ovarian germ cell malignancies carry a very poor prognosis. The use of surgery alone or in combination with radiation therapy does not appreciably increase survival. The combination of surgery, chemotherapy, and, in some instances, radiation therapy has accounted for an 89% two-year survival in 26 patients with germ cell malignancies of the ovary exclusive of "pure" dysgerminoma. Short-term chemotherapy appears as effective as the long-term therapy advocated by other investigators.
D000818:Animals; D004407:Dysgerminoma / Q000401:mortality / Q000473:pathology / Q000628:therapy; D005260:Female; D008649:Mesonephroma / Q000401:mortality / Q000473:pathology / Q000628:therapy; D009373:Neoplasms, Germ Cell and Embryonal / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D013724:Teratoma / Q000401:mortality / Q000473:pathology / Q000628:therapy